Company · CIK 0001822929
Eucrates Biomedical Acquisition Corp.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Virgin Islands, British
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 10-KAnnual report0001410578-23-000637 · 5.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-044086 · 274.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-040852 · 260.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-022812 · 312.8 KBSEC(opens sec.gov)
- SC 13G/AEucrates Biomedical Acquisition Corp.0001193805-23-000134 · 98.7 KBSEC(opens sec.gov)
- 10-QQuarterly update0001410578-22-003416 · 4.6 MBSEC(opens sec.gov)
- SC 13GEucrates Biomedical Acquisition Corp.0000834237-22-010992 · 12.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-22-115962 · 259.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-22-112977 · 576.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-22-110938 · 268.8 KBSEC(opens sec.gov)
Insiders
- Agarrwal AtanuuVice President
- CAMPBELL WILLIAM IDirector
- Cordova GonzaloChief Financial Officer
- Eucrates LLC10% Owner
- Karydas DaphneDirector
- PAPADOPOULOS STELIOSDirector, 10% Owner
- Sathe ShrikantSenior Vice President
- SAXENA PARAGDirector, Chief Executive Officer, 10% Owner
- Shapiro Nina B.Director
- Singhal AmitabhDirector
Tickers
No tickers on record.
Addresses
business
250 WEST 55TH STREET, SUITE 13D
NEW YORK, NY, 10019
mailing
250 WEST 55TH STREET, SUITE 13D
NEW YORK, NY, 10019
Same industry